Haemolytic uremic syndrome as a cause of chronic kidney disease stage 5 in children is in retreat: results from the Polish Registry of Kidney Replacement Therapy in children (2000–2023)
Pediatric Nephrology · 2025
DOI: 10.1007/s00467-024-06584-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Nephrology, 2025. Verfasst von Ilona Zagożdżon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nephrology and Hypertension, Medical University of Gdansk, Debinki 7, 80-211, Gdansk, Poland. ilona.zagozdzon@gumed.edu.pl. Hauptthemen laut MEDLINE: Hemolytic-Uremic Syndrome, Renal Replacement Therapy, Escherichia coli Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Haemolytic uremic syndrome (HUS) is a life-threatening disease with a historically poor prognosis in children receiving maintenance kidney replacement therapy (KRT). This study aimed to analyse the incidence and outcome of chronic kidney disease stage 5 (CKD5) due to Escherichia coli -HUS (STEC-HUS) and complement-mediated HUS (CM-HUS) in children, compared with controls with non-HUS CKD5 over the last 24 years.
Methods
The study included 1488 children undergoing KRT in Poland between 2000 and 2023. Thirty-nine patients with CM-HUS and 18 with STEC-HUS were identified and analysed for incidence, KRT modality and survival.
Results
The incidence rate of CKD5 was 0.09 cases/million age-related population (marp) for STEC-HUS and 0.23/marp for CM-HUS, while no new cases have been observed in recent years. CKD5 due to CM-HUS developed significantly earlier from initial HUS manifestation than in STEC-HUS (median 0.2 vs. 9.8 years). CM-HUS was associated with younger age at initiation of KRT compared to STEC-HUS and non-HUS controls (median 6.0 years vs. 10.9 and 10.9 years), with higher risk of death (Hazard Ratio 1.92, 95% confidence interval 0.9–4.13) and worse 5-year kidney graft survival at 77%, 93% and 90%, respectively ( p < 0.001).
Conclusions
In recent years, both CM-HUS and STEC-HUS have become increasingly rare causes of CKD5 in children. CKD5 due to CM-HUS in the eculizumab era and due to STEC-HUS after improving supportive treatment is exceptional. Children on KRT due to STEC-HUS had a significantly better survival, shorter waiting time for kidney transplantation and better kidney graft survival compared to the CM-HUS group. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Nephrology and Hypertension, Medical University of Gdansk, Debinki 7, 80-211, Gdansk, Poland. ilona.zagozdzon@gumed.edu.pl.
- Department and Clinic of Pediatrics, Nephrology and Endocrinology, Medical University of Silesia, Zabrze, Poland.
- Department of Nephrology and Kidney Transplantation, The Childrens Memorial Health Institute, Warsaw, Poland.
- Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Krakow, Poland.
- Department of Pediatric Cardiology and Nephrology, Poznan University of Medical Sciences, Poznan, Poland.
- Department of Pediatrics, Immunology and Nephrology, Polish Mother's Memorial Hospital - Research Institute in Lodz, Lodz, Poland.
Zitieren
APA
Zagożdżon, I., Szczepańska, M., Rubik, J., Zachwieja, K., Musielak, A., Bratkowska, M., Makulska, I., Niwińska, K., Leszczyńska, B., Bieniaś, B., Taranta-Janusz, K., Adamczyk-Kipigroch, H., & Żurowska, A. (2025). Haemolytic uremic syndrome as a cause of chronic kidney disease stage 5 in children is in retreat: results from the Polish Registry of Kidney Replacement Therapy in children (2000–2023). Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06584-2
Vancouver
Zagożdżon I, Szczepańska M, Rubik J, Zachwieja K, Musielak A, Bratkowska M, et al. Haemolytic uremic syndrome as a cause of chronic kidney disease stage 5 in children is in retreat: results from the Polish Registry of Kidney Replacement Therapy in children (2000–2023). Pediatric Nephrology. 2025. doi:10.1007/s00467-024-06584-2
BibTeX
@article{Zagodon2025,
author = {Zagożdżon, Ilona and Szczepańska, Maria and Rubik, Jacek and Zachwieja, Katarzyna and Musielak, Anna and Bratkowska, Monika and Makulska, Irena and Niwińska, Katarzyna and Leszczyńska, Beata and Bieniaś, Beata and Taranta-Janusz, Katarzyna and Adamczyk-Kipigroch, Hanna and Żurowska, Aleksandra},
title = {Haemolytic uremic syndrome as a cause of chronic kidney disease stage 5 in children is in retreat: results from the Polish Registry of Kidney Replacement Therapy in children (2000–2023)},
journal = {Pediatric Nephrology},
year = {2025},
doi = {10.1007/s00467-024-06584-2}
}
EUVIMED